Finance

Lists
CHM:ASX
Chimeric Therapeutics Ltd
0,0030 A$
0,00%
(0,00) 1D
30 սեպ, 17:11:03 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for CHM...
Mkt. cap
177,19 հզր
Avg. vol.
2,39 մլն
Volume
0,00
52-wk high
0,40 A$
52-wk low
0,00 A$
EPS
-0,61 A$
Shares outstanding
147,46 մլն
Mkt. cap
177,19 հզր
Avg. vol.
2,39 մլն
Volume
0,00
52-wk high
0,40 A$
52-wk low
0,00 A$
EPS
-0,61 A$
Shares outstanding
147,46 մլն
News stories
From web sources and news partners
About Chimeric Therapeutics Ltd
CEO-
Employees-
Founded2020
Headquarters-
Sector-
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
1,31 մլն
1,31 մլն
-1,40 մլն
-1,40 մլն
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
399,44 հզր
399,44 հզր
1,31 մլն
1,31 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,35 մլն
1,35 մլն
953,59 հզր
953,59 հզր
Operating expense
1,94 մլն
1,94 մլն
2,23 մլն
2,23 մլն
Total operating expenses
1,94 մլն
1,94 մլն
2,23 մլն
2,23 մլն
Operating income
-634,86 հզր
-634,86 հզր
-3,64 մլն
-3,64 մլն
Other non operating income
-
-
-8,94 հզր
-8,94 հզր
EBT including unusual items
-5,59 մլն
-5,59 մլն
-3,81 մլն
-3,81 մլն
EBT excluding unusual items
-709,86 հզր
-709,86 հզր
-3,55 մլն
-3,55 մլն
Income tax expense
21,60 հզր
21,60 հզր
-10,53 հզր
-10,53 հզր
Effective tax rate
-0,39%
-0,39%
0,28%
0,28%
Other operating expenses
-
-
-
-
Net income
-5,61 մլն
-5,61 մլն
-3,80 մլն
-3,80 մլն
Net profit margin
-428,19%
-428,19%
270,30%
270,30%
Earnings per share
-
-
-
-
Interest and investment income
13,78 հզր
13,78 հզր
5,84 հզր
5,84 հզր
Interest expense
-88,79 հզր
-88,79 հզր
-55,19 հզր
-55,19 հզր
Net interest expenses
-75,01 հզր
-75,01 հզր
-49,35 հզր
-49,35 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-391,47 հզր
-391,47 հզր
-3,62 մլն
-3,62 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps